Search clinical trials for: Rosuvastatin (crestor)
Total 0 results
Nothing found
Sponsors and Collaborators
- Amy Farabaugh, PhD
- Daily Centre for Psychiatry and Speech Disorders Poland
- North Tees and Hartlepool NHS Foundation Trust
- Kevin W Hatton, MD, PhD
- Skin Laser & Surgery Specialists
- University of Crete Medical School - University Hospital of Heraklion
- Emergency Medical Service Ostrava, Ostrava, Czech Republic
- Metiv Israel Psychotrauma Center
- Institute of Child Health, London, England
- Italian Academy of Rhinology
- Iran Ministry of Health, Treatment, and Medical Education
- Permanente Dental Associates Group, Oregon
- INESC TEC - Institute for Systems and Computer Engineering, Technology and Science (Porto, Portugal)
- Child Medical Center, 3 Rue de la Prugne, 63540 Romagnat, France
- EULAR Lupus Nephritis Trial Network Study Group
- Hospital of Southern Jutland
- Meng Li
- Anthony Johnson
- Spital Linth
- Azienda Sanitaria Locale N.1 dell'Umbria
- View Full List
Medical Conditions
- Non-small Cell Lung Cancer Stage ⅢA
- Exercise Intolerance, Riboflavin-Responsive
- Peripheral T-cell Lymphomas
- Neuralgia, Postherpetic
- Mastoid Cavity
- Post-micturition Incontinence
- Haematologic Disease
- Metformin Concentration
- Laxative Compatibility
- Thyroid Eye Disease
- Leiomyomas
- Crystal Meth Addiction
- Sodium Selenite
- Tendon CSA
- Indirect Incentive
- Management of Lung Cancer Patients
- Working Memory Training
- Relapsed/Refractory Large B-cell Lymphoma
- Primary Lymphoma of the Central Nervous System
- Peptic Ulcer With Haemorrhage
- View Full List
Drug Interventions
- Tranexamic acid
- Percutaneous sirolimus
- Ketamine 0.3 mg/kg at anesthesia induction
- Anastrozole
- Granulocyte colony-stimulating factor
- Vinorelbine tartrate
- Sodium Nitroprusside
- Tenofovir
- PCO371
- 5.0g SRT501
- Amisulpride Oral Tablet
- Visanne (Dienogest, BAY86-5258)
- Follitropin beta liquid formulation
- Nicoderm C-Q Transdermal Product
- 30 mg CVL-231 as slow-release MR formulation
- 6-Mercaptopurine
- Trastuzumab in combination with SubQ GM-CSF
- Modified Bolus 5-FU/LV with Irinotecan
- Sipuleucel-T
- Cetuximab
- View Full List
CROs by country
- Contract Research Organizations in Burundi
- Contract Research Organizations in Chile
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Ecuador
- Contract Research Organizations in France
- Contract Research Organizations in Georgia
- Contract Research Organizations in Ghana
- Contract Research Organizations in Iran
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Mongolia
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Zambia
- CRO list by country